Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls

OBJECTIVE: To investigate changes in the cerebrospinal fluid (CSF) immunological profile after treatment switch from first-line injectables to rituximab in patients with relapsing-remitting MS (RRMS), and to compare the profile in MS patients with healthy controls (HC). METHOD: Cerebrospinal fluid f...

Descripción completa

Detalles Bibliográficos
Autores principales: de Flon, Pierre, Söderström, Lars, Laurell, Katarina, Dring, Ann, Sundström, Peter, Gunnarsson, Martin, Svenningsson, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805315/
https://www.ncbi.nlm.nih.gov/pubmed/29420590
http://dx.doi.org/10.1371/journal.pone.0192516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805315/
https://www.ncbi.nlm.nih.gov/pubmed/29420590
http://dx.doi.org/10.1371/journal.pone.0192516

Ejemplares similares